Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

the cigna group - CI

CI

Close Chg Chg %
331.31 0.57 0.17%

Closed Market

331.88

+0.57 (0.17%)

Volume: 1.11M

Last Updated:

Apr 2, 2025, 3:59 PM EDT

Trade Now

Company Overview: the cigna group - CI

CI Key Data

Open

$329.09

 Day Range

327.48 - 332.65

52 Week Range

262.03 - 370.83

 Market Cap

$89.74B

Shares Outstanding

271.11M

 Public Float

266.80M

Beta

0.52

 Rev. Per Employee

N/A

P/E Ratio

27.30

 EPS

$12.39

Yield

172.51%

 Dividend

$1.51

EX-DIVIDEND DATE

Mar 5, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.64M

  

CI Performance

1 Week
 
 1.83%
 
1 Month
 
 7.17%
 
3 Months
 
 17.92%
 
1 Year
 
 -8.68%
 
5 Years
 
 102.03%
 

CI Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 27
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 362.727
Number of Ratings 27 Current Quarters Estimate 7.185
FY Report Date 06 / 2025 Current Year's Estimate 29.60
Last Quarter’s Earnings 6.36 Median PE on CY Estimate N/A
Year Ago Earnings 27.33 Next Fiscal Year Estimate 33.021
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 22 22 22 21
Mean Estimate 7.18 8.04 29.60 33.02
High Estimates 7.49 8.59 29.78 34.15
Low Estimate 6.85 7.61 29.50 32.25
Coefficient of Variance 2.11 2.52 0.30 1.51

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 17 17 16
OVERWEIGHT 3 3 6
HOLD 7 7 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for The Cigna Group - CI

Date Name Shares Transaction Value
Mar 12, 2025 Noelle K. Eder See Remarks 13,406 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $320 per share 4,289,920.00
Jun 20, 2024 Elder Granger Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 20, 2024 Elder Granger Director 5,471 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $331.38 per share 1,812,979.98
Jun 20, 2024 Elder Granger Director 6,018 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $175.09 per share 1,053,691.62
Jun 5, 2024 Eric C. Wiseman Director 7,909 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 5, 2024 George Kurian Director 1,082 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Noelle K. Eder See Remarks N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Noelle K. Eder See Remarks 875 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Noelle K. Eder See Remarks 16,699 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $171.38 per share 2,861,874.62
May 17, 2024 Noelle K. Eder See Remarks 15,824 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $348.47 per share 5,514,189.28
May 17, 2024 Mary Terese Agoglia Hoeltzel SVP Tax & Chief Acct. Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 17, 2024 Mary Terese Agoglia Hoeltzel SVP Tax & Chief Acct. Officer 2,595 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $348.71 per share 904,902.45
May 17, 2024 Mary Terese Agoglia Hoeltzel SVP Tax & Chief Acct. Officer 8,541 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $120.9 per share 1,032,606.90
Apr 29, 2024 William J. DeLaney Director 17,539 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 29, 2024 Philip O. Ozuah Director 1,163 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 29, 2024 Neesha Hathi Director 2,731 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 29, 2024 Mark B. McClellan Director 5,471 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 29, 2024 Kimberly A. Ross Director 3,874 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 29, 2024 Eric J. Foss Director 35,276 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 29, 2024 Donna F. Zarcone Director 26,097 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

The Cigna Group in the News